| Structure-preserving color normalization and sparse stain separation for histological images A Vahadane, T Peng, A Sethi, S Albarqouni, L Wang, M Baust, K Steiger, ... IEEE transactions on medical imaging 35 (8), 1962-1971, 2016 | 598 | 2016 |
| Exploring the role of RGD-recognizing integrins in cancer M Nieberler, U Reuning, F Reichart, J Notni, HJ Wester, M Schwaiger, ... Cancers 9 (9), 116, 2017 | 387 | 2017 |
| Evolutionary routes and KRAS dosage define pancreatic cancer phenotypes S Mueller, T Engleitner, R Maresch, M Zukowska, S Lange, ... Nature 554 (7690), 62-68, 2018 | 371 | 2018 |
| PD-1 is a haploinsufficient suppressor of T cell lymphomagenesis T Wartewig, Z Kurgyis, S Keppler, K Pechloff, E Hameister, R Öllinger, ... Nature 552 (7683), 121-125, 2017 | 244 | 2017 |
| NRG1 Fusions in KRAS Wild-Type Pancreatic Cancer C Heining, P Horak, S Uhrig, PL Codo, B Klink, B Hutter, M Fröhlich, ... Cancer discovery 8 (9), 1087-1095, 2018 | 216 | 2018 |
| CRISPR/Cas9 somatic multiplex-mutagenesis for high-throughput functional cancer genomics in mice J Weber, R Öllinger, M Friedrich, U Ehmer, M Barenboim, K Steiger, I Heid, ... Proceedings of the National Academy of Sciences 112 (45), 13982-13987, 2015 | 216 | 2015 |
| Multiplexed pancreatic genome engineering and cancer induction by transfection-based CRISPR/Cas9 delivery in mice R Maresch, S Mueller, C Veltkamp, R Öllinger, M Friedrich, I Heid, ... Nature communications 7 (1), 10770, 2016 | 197 | 2016 |
| Somatostatin receptor expression related to TP53 and RB1 alterations in pancreatic and extrapancreatic neuroendocrine neoplasms with a Ki67-index above 20% B Konukiewitz, AM Schlitter, M Jesinghaus, D Pfister, K Steiger, A Segler, ... Modern Pathology 30 (4), 587-598, 2017 | 192 | 2017 |
| Colorectal mixed adenoneuroendocrine carcinomas and neuroendocrine carcinomas are genetically closely related to colorectal adenocarcinomas M Jesinghaus, B Konukiewitz, G Keller, M Kloor, K Steiger, M Reiche, ... Modern Pathology 30 (4), 610-619, 2017 | 148 | 2017 |
| Imaging of pH in vivo using hyperpolarized 13C-labelled zymonic acid S Düwel, C Hundshammer, M Gersch, B Feuerecker, K Steiger, A Buck, ... Nature communications 8 (1), 15126, 2017 | 123 | 2017 |
| Molecular, morphological and survival analysis of 177 resected pancreatic ductal adenocarcinomas (PDACs): Identification of prognostic subtypes AM Schlitter, A Segler, K Steiger, CW Michalski, C Jäger, B Konukiewitz, ... Scientific reports 7 (1), 41064, 2017 | 107 | 2017 |
| Structure-preserved color normalization for histological images A Vahadane, T Peng, S Albarqouni, M Baust, K Steiger, AM Schlitter, ... 2015 IEEE 12th international symposium on biomedical imaging (ISBI), 1012-1015, 2015 | 106 | 2015 |
| Pancreatic neuroendocrine carcinomas reveal a closer relationship to ductal adenocarcinomas than to neuroendocrine tumors G3 B Konukiewitz, M Jesinghaus, K Steiger, AM Schlitter, A Kasajima, ... Human pathology 77, 70-79, 2018 | 105 | 2018 |
| Tumour budding activity and cell nest size determine patient outcome in oral squamous cell carcinoma: proposal for an adjusted grading system M Boxberg, M Jesinghaus, C Dorfner, C Mogler, E Drecoll, A Warth, ... Histopathology 70 (7), 1125-1137, 2017 | 104 | 2017 |
| A conditional piggyBac transposition system for genetic screening in mice identifies oncogenic networks in pancreatic cancer R Rad, L Rad, W Wang, A Strong, H Ponstingl, IF Bronner, M Mayho, ... Nature genetics 47 (1), 47-56, 2015 | 96 | 2015 |
| ER stress protein AGR2 precedes and is involved in the regulation of pancreatic cancer initiation L Dumartin, W Alrawashdeh, SM Trabulo, TP Radon, K Steiger, ... Oncogene 36 (22), 3094-3103, 2017 | 91 | 2017 |
| Pancreatic ductal adenocarcinoma subtyping using the biomarkers hepatocyte nuclear factor-1A and cytokeratin-81 correlates with outcome and treatment response A Muckenhuber, AK Berger, AM Schlitter, K Steiger, B Konukiewitz, ... Clinical Cancer Research 24 (2), 351-359, 2018 | 89 | 2018 |
| Targeting mannose receptor expression on macrophages in atherosclerotic plaques of apolipoprotein E-knockout mice using 111In-tilmanocept Z Varasteh, F Hyafil, N Anizan, D Diallo, R Aid-Launais, S Mohanta, Y Li, ... EJNMMI research 7, 1-9, 2017 | 88 | 2017 |
| Co-clinical assessment of tumor cellularity in pancreatic cancer I Heid, K Steiger, M Trajkovic-Arsic, M Settles, MR Eßwein, M Erkan, ... Clinical Cancer Research 23 (6), 1461-1470, 2017 | 87 | 2017 |
| PD-L1 and PD-1 and characterization of tumor-infiltrating lymphocytes in high grade sarcomas of soft tissue–prognostic implications and rationale for immunotherapy M Boxberg, K Steiger, U Lenze, H Rechl, R von Eisenhart-Rothe, ... Oncoimmunology 7 (3), e1389366, 2018 | 85 | 2018 |
